The move is expected to make medicines available as companies faced a rise in prices of active pharmaceutical ingredients (APIs), a major raw material.
first published: Dec 18, 2019 05:45 pm
A collection of the most-viewed Moneycontrol videos.
Live: Nifty slips below 24,800 as breadth weakens; SMIDs underperform | Closing Bell
Live: Nifty eyes broader market volatility, FOMC outcome for next cues | Opening Bell
Live: Nifty recovers 100 pts from day's lows in a choppy session; smallcaps shine | Closing Bell
Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
